DK3269731T5 - Molekylært design af rekombinant proteinlægemiddel - Google Patents

Molekylært design af rekombinant proteinlægemiddel Download PDF

Info

Publication number
DK3269731T5
DK3269731T5 DK16748749.5T DK16748749T DK3269731T5 DK 3269731 T5 DK3269731 T5 DK 3269731T5 DK 16748749 T DK16748749 T DK 16748749T DK 3269731 T5 DK3269731 T5 DK 3269731T5
Authority
DK
Denmark
Prior art keywords
recombinant protein
protein drug
molecular design
molecular
design
Prior art date
Application number
DK16748749.5T
Other languages
Danish (da)
English (en)
Other versions
DK3269731T3 (da
Inventor
Yongzhang Luo
Peng Liu
Xinan Lu
Original Assignee
Univ Tsinghua
Beijing Protgen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tsinghua, Beijing Protgen Ltd filed Critical Univ Tsinghua
Application granted granted Critical
Publication of DK3269731T3 publication Critical patent/DK3269731T3/da
Publication of DK3269731T5 publication Critical patent/DK3269731T5/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1891Angiogenesic factors; Angiogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK16748749.5T 2015-02-13 2016-02-14 Molekylært design af rekombinant proteinlægemiddel DK3269731T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510079486 2015-02-13
CN201510736184 2015-11-02
PCT/CN2016/073773 WO2016127948A1 (zh) 2015-02-13 2016-02-14 一种重组蛋白质药物的分子设计

Publications (2)

Publication Number Publication Date
DK3269731T3 DK3269731T3 (da) 2023-10-30
DK3269731T5 true DK3269731T5 (da) 2024-10-14

Family

ID=56614147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16748749.5T DK3269731T5 (da) 2015-02-13 2016-02-14 Molekylært design af rekombinant proteinlægemiddel

Country Status (8)

Country Link
US (2) US10869910B2 (enExample)
EP (1) EP3269731B1 (enExample)
JP (1) JP6896636B2 (enExample)
CN (2) CN114249816B (enExample)
AU (2) AU2016218635B2 (enExample)
CA (1) CA3014538A1 (enExample)
DK (1) DK3269731T5 (enExample)
WO (1) WO2016127948A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890155B (zh) * 2010-05-25 2012-07-25 江苏先声药物研究有限公司 一种药物组合物及其应用
WO2013034116A1 (zh) * 2011-09-09 2013-03-14 清华大学 对atp结合位点进行突变的血管内皮抑制素突变体
CN107148277B (zh) * 2014-11-03 2022-03-22 清华大学 一种抑制脂肪细胞分化和胰岛素耐受的药物

Also Published As

Publication number Publication date
EP3269731A4 (en) 2018-08-15
JP6896636B2 (ja) 2021-06-30
EP3269731B1 (en) 2023-10-04
AU2020256316A1 (en) 2020-11-12
CA3014538A1 (en) 2016-08-18
AU2016218635A1 (en) 2017-10-05
CN114249816A (zh) 2022-03-29
CN114249816B (zh) 2024-09-06
CN107428809A (zh) 2017-12-01
WO2016127948A1 (zh) 2016-08-18
US20180200337A1 (en) 2018-07-19
US20210085754A1 (en) 2021-03-25
JP2018507854A (ja) 2018-03-22
AU2016218635B2 (en) 2020-07-23
AU2020256316B2 (en) 2021-10-07
US10869910B2 (en) 2020-12-22
DK3269731T3 (da) 2023-10-30
EP3269731A1 (en) 2018-01-17
CN107428809B (zh) 2021-10-01

Similar Documents

Publication Publication Date Title
LT3428194T (lt) Pagerinta dvejopo savitumo polipeptido molekulė
IL254516B (en) Proteins specific for cd137
EP3362556C0 (en) POLYPEPTIDE VARIANTS
DK3292141T3 (da) Fusionsproteiner
PL3649151T3 (pl) Białka rusztowania
EP3450452A4 (en) MODIFIED FIBROIN
DK3805376T3 (da) Modificeret virus
EP3450451A4 (en) MODIFIED FIBROIN
DK3244948T3 (da) Bestemmelse af medikamentdosis
PL3498292T3 (pl) Konstrukty białka uspa2 i ich zastosowania
DK3199179T3 (da) Formulering af rekombinant fusionsprotein
EP3476859A4 (en) MODIFIED FIBROIN
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
HUE051184T2 (hu) Baktériumalapú fehérjeszállítás
DK3350334T3 (da) Udtryk af rekombinante proteiner i trichoplusia ni pupper
EP3355931C0 (en) PROTEIN CONJUGATES
DK3463345T3 (da) Farmaceutiske kombinationer
DK3259358T3 (da) Forøget proteinekspression
EP3437644A4 (en) MEDICINE
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
EP3522698A4 (en) NEW INSECTICIDE PROTEINS
DK3448879T3 (da) Claudin-6 peptider
EP3377633C0 (en) PRODUCTION OF RECOMBINANT PROTEINS
DK3310331T3 (da) Injicerbare farmaceutiske formuleringer af lefamulin
DK3271724T3 (da) Anvendelse af en standard til påvisning af proteinaggregater i en proteinfejlfoldningssygdom